Barely Significant
← all excerpts

Specific Antibodies and Arachidonic Acid Mediate the Protection Induced by the <i>Schistosoma mansoni</i> Cysteine Peptidase-Based Vaccine in Mice.

Vaccines (Basel) · 2020 · PMC7712720 · PMID 33207535

Europe PMCDOI
1
hedged sentence
0.0050
closest p · 0.1× alpha
0.0050
boldest claim

The sentences

highly significantp < 0.005actually significant
Introduction A non-adjuvanted cysteine peptidase-based vaccine represents a means of alleviating schistosomiasis symptoms and reducing transmission, as it consistently and repeatedly elicits a highly significant ( p < 0.005, p < 0.0001) reduction in challenge Schistosoma mansoni and Schistosoma haematobium burden in mice and hamsters [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.